PROCEPT BioRobotics (PRCT) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
PROCEPT BioRobotics is the larger company by market cap ($1.02 billion vs $799.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRCT | SGP |
|---|---|---|
| Share price | $17.91 | $23.90 |
| Market cap | $1.02B | $799.41M |
| 1-day change | +2.28% | -3.55% |
| YTD return | -43.07% | — |
| 1-year return | -48.25% | — |
| 5-year return | -58.89% | — |
| EPS (TTM) | $-1.94 | $-2.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $38.11 | $32.44 |
| 52-week low | $16.67 | $17.06 |
| Distance from 52-week high | -53.00% | -26.33% |
| Average volume | 1.46M | 112.24K |
| Shares outstanding | 56.92M | 33.45M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PRCT vs SGP FAQ
Which is bigger, PROCEPT BioRobotics or SpyGlass Pharma?
PROCEPT BioRobotics (PRCT) is larger, with a market capitalization of $1.02B compared with $799.41M for SpyGlass Pharma (SGP).
Are PROCEPT BioRobotics and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.